Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.
Recruiting · NCT04703166 · Registry updated 2026-05-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. | Arrhythmias, Cardiac, Heart Murmurs, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2026-05-19 | NCT04703166 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Preventice | 1 |
| Samsung | 2 |
| Tulane University School of Medicine | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tulane University School of Medicine | New Orleans | United States | 47 |